Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$505K Sell
1,394
-3
-0.2% -$1.03K 0.11% 101
2026
Q1
$492K Buy
1,397
+3
+0.2% +$1.07K 0.11% 96
2025
Q4
$456K Sell
1,394
-6
-0.4% -$1.9K 0.12% 101
2025
Q3
$395K Buy
1,400
+17
+1% +$4.93K 0.11% 112
2025
Q2
$386K Sell
1,383
-21
-1% -$5.95K 0.11% 104
2025
Q1
$437K Buy
1,404
+21
+2% +$6.2K 0.13% 91
2024
Q4
$360K Sell
1,383
-16
-1% -$4.75K 0.11% 113
2024
Q3
$451K Sell
1,399
-22
-2% -$7.2K 0.14% 86
2024
Q2
$444K Sell
1,421
-11
-0.8% -$3.23K 0.14% 84
2024
Q1
$407K Sell
1,432
-436
-23% -$128K 0.14% 100
2023
Q4
$538K Buy
1,868
+34
+2% +$9.26K 0.21% 76
2023
Q3
$493K Buy
1,834
+141
+8% +$35.2K 0.29% 58
2023
Q2
$376K Buy
+1,693
New +$393K 0.19% 73
2021
Q3
Sell
-864
Closed -$211K 83
2021
Q2
$211K Buy
+864
New +$213K 0.2% 76
2021
Q1
Sell
-1,081
Closed -$249K 84
2020
Q4
$249K Buy
+1,081
New +$249K 0.31% 58

Other funds holding AMGN

Opal Wealth Advisors's AMGN Position: Q2 2026 in Review

Opal Wealth Advisors reduced its Amgen (AMGN) stake by 0.21% in Q2 2026, selling an estimated $1.03K and leaving 1,394 shares worth $505K. The position accounts for 0.11% of the portfolio, ranked #101.

Opal Wealth Advisors first reported a position in AMGN in Q4 2020 and has held it in 15 quarters since. The position peaked at $538K in Q4 2023. 1,554 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Opal Wealth Advisors held 1,394 shares of Amgen worth $505K as of Q2 2026.
  • Opal Wealth Advisors sold 3 Amgen shares in Q2 2026, an estimated $1.03K.
  • Amgen made up 0.11% of Opal Wealth Advisors's portfolio in Q2 2026, its #101 holding.
  • Opal Wealth Advisors first reported a position in Amgen in Q4 2020 and has held it in 15 quarters since.
  • Opal Wealth Advisors's Amgen position peaked at $538K in Q4 2023.
  • 1,554 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Opal Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.